Magnetic resonance imaging contrast agent related pulmonary edema: a case report

A. Demirhan, U. Yasar Tekelioglu, A. Akkaya, E. Dagistan, S. Suzi Ayhan, S. Ozturk, I. Yildiz, H. Kocoglu

Department of Anesthesiology and Reanimation, Abant Izzet Baysal, University Medical School, Bolu, Turkey. dr_demirhan1@hotmail.com
Department of Radiology, Abant Izzet Baysal University Medical School, Bolu, Turkey
Department of Cardiology, Abant Izzet Baysal University Medical School, Bolu, Turkey
Department of Anesthesiology and Reanimation, Abant Izzet Baysal University Medical School, Bolu, Turkey
Department of Anesthesiology and Reanimation, Abant Izzet Baysal University Medical School, Bolu, Turkey

---

• Nuclear Medicine

Gadobutrol is a contrast agent often used during magnetic resonance imaging (MRI). The agent has several side effects, some of which can be serious. It has extremely rare life-threatening systemic complications, which can lead to bronchospasm, hypersensitivity reactions and cardiovascular arrest. However, there is no data available on the development of noncardiogenic pulmonary edema following use of gadobutrol. This paper examines the case of a 37-year-old male patient reported to have developed noncardiogenic pulmonary edema after intravenous injection of gadobutrol during MRI.

Published on: 2012/10/17

Free PDF Download